MedSci Doctors discuss - COVID19 Flu and Immune Health

Un-edited discussion
Date:  2020-04-22
Author:   Dr. Sean Hall , Professor Luis Vitetta , Courtney Fletcher

In this raw Un-edited recording, Dr Sean Hall and Dr Luis Vitetta and Courtney Fletcher discuss COVID19 Flu and Immune Health.

Disclaimer - This information may include the views or recommendations of the participants and is not intended to be a substitute for professional or medical advice.


Tell us what you think login to share your thoughts.


Dr. Sean Hall, Chief Executive Officer of Medlab
Chief Executive Officer
Dr. Sean Hall

Sean founded Medlab in August 2012; he has over 20 years' experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the US. Sean has led and inspired his teams to author multiple patents, write peer-reviewed articles and deliver lectures at scientific conferences. His passion is leading his researchers into novel areas and strong commercialisation opportunities.

Prior Sean was a founder of FIT-BioCeuticals. Under his management and guidance, BioCeuticals became the most innovative, research-driven, practitioner brand in Australia. For his sale of FIT-BioCeuticals to Blackmores in 2012, Sean was nominated as a finalist in the inaugural Australian Exit CEO of the Year Award. Sean is a Medical Doctor with an MBA in clinical pharmaceutical management and focuses on the research to pioneer innovation and commercialisation. Sean is an active member of Medicines Australia, the European Medical Association, the American Federation for Medical Researcher, The World Medical Association, A4M and Special Operations Medical Association.

Professor Luis Vitetta, Director of Medical Research at Medlab
Director of Medical Research
Professor Luis Vitetta

Luis is Director of Medical Research at Medlab Clinical and Adjunct Professor at the University of Sydney, Sydney Medical School. Luis has an extensive depth of knowledge of the science behind effective probiotics and biologic medicines. His focus on clinical research and its relevance to commercialisation informs Medlab's product portfolio.

After many years of educating clinicians, pharmacists, undergraduate and postgraduate students, Luis is in a strong position to advance Medlab's clinical research activities and drug innovation projects to the clinical practitioner community.

Courtney Fletcher - Life Science Educator
Life Science Educator
Courtney Fletcher

Courtney holds a B.H.S (Nut)  and has developed a career dedicated to allied health and pharmacy solutions providing diagnostic, technical, therapeutic and direct patient care and support. Courtney provides vital assistance to patients and works alongside medical teams including doctors, allied health practitioner and pharmacists to deliver the best possible patient outcomes.

With her past decade of experience in the film and television industry and as a business owner, a change in professional interest took place. In the last four years she has committed to her education and formally started to work within a scientific clinical framework at Medlab Clinical and her own Nutritional Clinic.

In her current capacity at Medlab Clinical, Courtney develops technical educational material to support conference presentations about Medlab’s research and publications. Her role has expanded beyond the boundaries of a traditional educator which includes presenting at educational and training events, working alongside the sales and marketing team to support sales targets and performance and creates digital assets including blogs, videos and webinars.


Medlab Research Update: SAMe and Magnesium Orotate as Adjunctive to SSRIs

Anti-depressants are first line treatment for moderate to severe depression and offer benefits both short and long term. Important problems persist such as intolerability, delayed therapeutic onset, limited efficacy in milder depression and the existence of treatment-resistant depression.


Medlab Research Update: Probiotic and Magnesium Orotate as Adjunctive to SSRIs

Medlab’s Phase II clinical study continues to explore adjunctive administration of pharmaceuticals such as Selective Serotonin Reuptake Inhibitors (SSRIs) for treatment resistant depression. Medlab’s pilot study investigating SAMe and Magnesium Orotate suggested that intestinal dysbiosis was implicated in depression with systemic inflammation and possible impairment of vagal nerve signaling. Therefore, further investigations should include a diagnostic examination for gastrointestinal tract dysfunction followed by intervention with specific probiotic strains to improve a dysbiotic gastrointestinal tract that could enhance a patient's response to treatments taken orally for depression.  


Medlab Research Update: NanoCelle

NanoCelle® Technology - is a unique delivery platform that has demonstrated effective and convenient delivery of an active ingredient administered as a spray onto the oro-buccal membrane (inside of the cheek). The aim of Medlab’s clinical study with healthy participants was to compare the absorption profiles over a 6-hour period of five different vitamin B12 formulations, administered via the oral-intestinal tract, oral mucosa and oro-buccal sites.